Fludarabine monophosphate for prolymphocytic leukaemia.
Smith
O P
OP
Mehta
A B
AB
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001088:Arabinonucleotides / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000188:drug therapy*; D008297:Male; D012074:Remission Induction / Q000379:methods; D001084:Vidarabine Phosphate / Q000008:administration & dosage* / Q000031:analogs & derivatives
D000964:Antimetabolites, Antineoplastic; D001088:Arabinonucleotides; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate